Clinical Trial

The RESPLASH Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To assess the safety and effectiveness of renal artery denervation with subsequent splanchnic nerves denervation via catheter-based radiofrequency ablation in improving blood pressure and glycemic control in patients with resistant hypertension and type 2 diabetes.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-03-11; most recent amendment 2026-02-27.
Trial Details
NCT Number NCT06880562
Lead Sponsor Tulane University
Conditions Resistant Hypertension
Enrollment 20 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-03-03